Genetics Generation Advancement (ROCO:4160) EPS (Basic) : NT$1.82 (TTM As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Genetics Generation Advancement EPS (Basic)?

Genetics Generation Advancement's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was NT$0.29. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$1.82.

Genetics Generation Advancement's EPS (Diluted) for the three months ended in Mar. 2025 was NT$0.29. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$1.80.

Genetics Generation Advancement's EPS without NRI for the three months ended in Mar. 2025 was NT$0.29. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 1.80.

During the past 12 months, Genetics Generation Advancement's average EPS without NRIGrowth Rate was 39.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 91.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Genetics Generation Advancement's highest 3-Year average EPS without NRI Growth Rate was 91.40% per year. The lowest was -22.70% per year. And the median was 13.00% per year.

Genetics Generation Advancement EPS (Basic) Historical Data

The historical data trend for Genetics Generation Advancement's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetics Generation Advancement EPS (Basic) Chart

Genetics Generation Advancement Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-0.59

0.29

0.96

1.07

2.05

Genetics Generation Advancement Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.53	0.69	0.72	0.12	0.29

Genetics Generation Advancement EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Genetics Generation Advancement's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(54.698	-	0)	/	26.690
	=	2.05

Genetics Generation Advancement's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(7.652	-	0)	/	26.386
	=	0.29

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.82

Genetics Generation Advancement (ROCO:4160) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Genetics Generation Advancement EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Genetics Generation Advancement's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetics Generation Advancement Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetics Generation Advancement Corp (ROCO:4160) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494

Website

https://www.gga.asia

Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.

Genetics Generation Advancement Headlines

No Headlines